Exendin-4, a glucagon-like peptide-1 receptor agonist, suppresses pancreatic β-cell destruction induced by encephalomyocarditis virus

Biochemical and Biophysical Research Communications

Volumn 404, Issue 3, 2011, Pages 756-761

  Sano, Hiroyuki ^a   Terasaki, Jungo ^a   Mishiba, Yuko ^a   Imagawa, Akihisa ^b   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Diabetes; Encephalomyocarditis virus; Exendin 4; Glucagon like peptide 1; Macrophage

Indexed keywords

EXENDIN 4; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL DESTRUCTION; CELL INFILTRATION; CELL PROTECTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DRUG EFFECT; DRUG MEGADOSE; ENCEPHALOMYOCARDITIS VIRUS; IN VITRO STUDY; LOW DRUG DOSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; VIRUS INFECTION;

ANIMALS; APOPTOSIS; CARDIOVIRUS INFECTIONS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENCEPHALOMYOCARDITIS VIRUS; INSULIN-SECRETING CELLS; MACROPHAGES; MALE; MICE; PEPTIDES; RECEPTORS, GLUCAGON; VENOMS;

ENCEPHALOMYOCARDITIS VIRUS; MUS;

EID: 78751624331     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.020     Document Type: Article

References (30)

1. Hirata K., Kume S., Araki S., Sakaguchi M., Chin-Kanasaki M., Isshiki K., Sugimoto T., Nishiyama A., Koya D., Haneda M., Kashiwagi A., Uzu T. Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model. Biochem. Biophys. Res. Commun. 2009, 380:44-49.
2. Daneman D. Type1 diabetes. Lancet 2006, 367:847-858.
3. Knip M., Veijola R., M Virtanen S., Hyöty H., Vaarala O., Åkerblom H.K. Environmental triggers and determinants of type 1 diabetes. Diabetes 2005, 54:S125-S136.
4. Hanafusa T., Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:36-45.
5. Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset an absence of diabetes-related antibodies Osaka IDDM study group. N. Engl. J. Med. 2000, 342:301-307.
6. Imagawa A., Hanafusa T., Uchigata Y., Kanatsuka A., Kawasaki E., Kobayashi T., Shimada A., Shimizu I., Toyoda T., Maruyama T., Makino H. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 2003, 26:2345-2352.
7. Shibasaki S., Imagawa A., Tauriainen S., Iino M., Oikarinen M., Abiru H., Tamaki K., Seino H., Nishi K., Takase I., Okada Y., Uno S., Murase-Mishiba Y., Terasaki J., Makino H., Shimomura I., Hyöty H., Hanafusa T. Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes. Endocrinol. J. 2010, 57:211-219.
8. Tanaka S., Nishida Y., Aida K., Maruyama T., Shimada A., Suzuki M., Shimura H., Takizawa S., Takahashi M., Akiyama D., Arai-Yamashita S., Furuya F., Kawaguchi A., Kaneshige M., Katoh R., Endo T., Kobayashi T. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes 2009, 58:2285-2291.
9. Shimada A., Maruyama T. Encephalomyocarditis-virus-induced diabetes model resembles " fulminant" type 1 diabetes in humans. Diabetologia 2004, 47:1854-1855.
10. Greig N.H., Holloway H.W., De Ore K.A., Jani D., Wang Y., Zhou J., Garant M.J., Egan J.M. Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations. Diabetologia 1999, 42:45-50.
11. Kolterman O.G., Buse J.B., Fineman M.S., Gaines E., Heintz S., Bicsak T.A., Taylor K., Kim D., Aispoma M., Wang Y., Baron A.D. Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. J. Clin. Endocrinol. Metab. 2003, 88:3082-3089.
12. Parkes D.G., Pittner R., Jodka C., Smith P., Young A. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism 2001, 50:583-589.
13. Tews D., Lehr S., Hartwig S., Osmers A., Paslack W., Eckel J. Anti-apoptotic action of exendin-4 in INS-1 beta cells: comparative protein pattern analysis of isolated mitochondria. J. Horm. Metab. Res. 2009, 41:294-301.
14. Blandino-Rosano M., Perez-Arana G., Mellado-Gil J.M., Segundo C., Aguilar-Diosdado M. Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase1/2 pathway inhibition: protective role of glucagon-like peptide-1. J. Mol. Endocrinol. 2008, 41:35-44.
15. Bregenholt S., Møldrup A., Blume N., Karlsen A.E., Nissen Friedrichsen B., Tornhave D., Knudsen L.B., Petersen J.S. The long-acting glucagon-like peptide-1 analogue liraglutide inhibits beta-cell apoptosis in vitro. Biochem. Biophys. Res. Commun. 2005, 330:577-584.
16. Bulotta A., Farilla L., Hui H., Perfetti R. The role of GLP-1 in the regulation of islet cell mass. Cell Biochem. Biophys. 2004, 40:65-78.
17. Dan K., Seto Y., Fujita T., Asaba Y., Takei I., Fujita H., Kato R. Characterization of insulin-dependent diabetes mellitus induced by a new variant (DK-27) of encephalomyocarditis virus in DBA/2 mice. Exp. Anim. 1995, 44:211-218.
18. Yoon J.W., Notkins A.L. VI. Virus-induced diabetes mellitus. Genetically determined host differences in the replication of encephalomyocarditis virus in pancreatic beta cells. J. Exp. Med. 1976, 143:1170-1185.
19. Moran J.M., Moxley M.A., Buller R.M., Corbett J.A. Encephalomyocarditis virus induces PKR-independent mitogen-activated protein kinase activation in macrophages. J. Virol. 2005, 79:10226-10236.
20. Arakawa M., Mita T., Azuma K., Ebato C., Goto H., Nomiyama T., Fujitani Y., Hirose T., Kawamori R., Watada H. Inhibition of monocyte adhesion to endothelial cells attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist exendin-4. Diabetes 2010, 59:1030-1037.
21. Li L., El-Kholy W., Rhodes C.J., Brubaker P.L. Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia 2005, 48:1339-1349.
22. Szayna M., Doyle M.E., Betkey J.A., Holloway H.W., Spencer R.G., Greig N.H., Egan J.M. Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats. Endocrinology 2000, 141:1936-1941.
23. Noyan-Ashraf M.H., Momen M.A., Ban K., Sadi A.M., Zhou Y.G., Riazi A.M., Baggio L.L., Henkelman R.M., Husain M., Drucker D.J. GLP-IR agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice. Diabetes 2009, 58:975-983.
24. Bose A.K., Mocanu M.M., Carr R.D., Brand C.L., Yellon D.M. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 2005, 54:146-151.
25. Nikolaidis L.A., Elahi D., Hentosz T., Doverspike A., Huerbin R., Zourelias L., Stolarski C., Shen Y.T., Shannon R.P. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. Circulation 2004, 110:955-961.
26. Baek H.S., Yoon Y.W. Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 1990, 64:5708-5715.
27. Baek H.S., Yoon J.W. Direct involvement of macrophages in destruction of beta-cells leading to development of diabetes in virus-infected mice. Diabetes 1991, 40:1586-1597.
28. Davalli A.M. Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 1995, 44:104-111.
29. Brubaker P.L., Drucker D.J. Minireview: glucagon-like peptides regulate cell proliferation apoptosis in the pancreas, gut, and central nervous system. Endocrinology 2004, 145:2653-2659.
30. Hirasawa K., Jun H.S., Maeda K., Kawaguchi Y., Itagaki S., Mikami T., Baek H.S., Doi K., Yoon J.W. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 1997, 71:4024-4031.